19 Hrs
Source:
Financial Times
QuidelOrtho considers selling testing division
Shares of the diagnostic company have declined by 90% since its rapid antigen tests became the first to receive approval for Covid-19 testing.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)